Page 81 - IngresoDr.MtzLanao

Elliot GH. (1933). The rates of solubility of tablets. A method for its determination. Pharm J., 131:
514.

Euteneuer JC, Kamatkar S, Fukuda T, Vinks AA, Akinbi HT (2019). Suggestions for Model-
Informed Precision Dosing to Optimize Neonatal Drug Therapy., J Clin Pharmacol. 59(2): 168-
176.

Faassen F, Vromans H (2004). Biowaivers for oral immediate-release products: implications of
linear pharmacokinetics. Clin Pharmacokinet., 43(15): 1117-1126.

Fernández-Caramés TM, Fraga-Lamas P, Suárez-Albela M, Vilar-Montesinos M (2018). A Fog
Computing and Cloudlet Based Augmented Reality System for the Industry 4.0 Shipyard. Sensors
(Basel). 18(6): 1798.

Fernández de Gatta MM, García MJ, Lanao JM, Domínguez-Gil A (1996). Bayesian forecasting in
paediatric populations. Clin Pharmacokinet., 31(5):325-330.

Fisher RA (1935). The design of experiments. Oliver & Boyd. Edinburgh.

Forrest WP, Mackey MA, Shah VM, Hassell KM, Shah P, Wylie JL, Gopinath J, Balderhaar H, Li L,
Wuelfing WP, Helmy (2017). Mixed Reality Meets Pharmaceutical Development. J Pharm Sci.
106(12): 3438-3441.

FDA Guidance for Industry Extended Release Solid Oral Dosage Forms: Development, Evaluation
and Application of In Vitro/In Vivo Correlations. 1997.

FDA. Pharmaceutical cGMP´s for the 21st century. A risk-based approach. September. 2004.

Friedrich C (1994). From Galen through modern pharmaceutical technology. Historical
development and overview. Pharmazie., 49(5): 307-312.

Furukawa R, Kadota K, Noguchi T, Shimosaka A, Shirakawa Y (2017). DEM Modelling of Granule
Rearrangement and Fracture Behaviours During a Closed-Die Compaction. AAPS PharmSciTech.,
18(6): 2368-2377.

Gao Y, Truong YB, Zhu Y, Kyratzis I (2014). Electrospun Antibacterial Nanofibers: Production,
Activity, and In Vivo Applications. J Appl Polym Sci. doi: 10.1002/app.40797

Gao Y, Teoh TW , Wang Q , Williams GR (2017). Electrospun organic-inorganic nanohybrids as
sustained release drug delivery systems. J Mater Chem B., 5(46): 9165-9174.

Garbayo E, Pascual-Gil S, Rodríguez-Nogales C, Saludas L, Estella-Hermoso de Mendoza A,
Blanco-Prieto MJ (2020). Nanomedicine and drug delivery systems in cancer and regenerative
medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol., 12(5): e1637.

García OF, Vallejo AM, Mora CE (2015). La calidad desde el diseño: principios y oportunidades
para la industria farmacéutica. Est Gerencial. 31: 68–78.

Geraci CL, Tinkle SS, Brenner SA, Hodson LL, Pomeroy-Carter CA, Neu-Baker N (2018). Launching
the dialogue: Safety and innovation as partners for success in advanced manufacturing. J Occup
Environ Hyg., 15(6): D45-D50.

79